BALIAKAS, Panagiotis, Michail ISKAS, Anne GARDINER, Zadie DAVIS, Karla PLEVOVÁ, Nguyen-Khac FLORENCE, Jitka MALČÍKOVÁ, Achlles ANAGNOSTOPOULOS, Sharron GLIDE, Sarah MOULD, Kristina ŠTĚPANOVSKÁ, Martin BREJCHA, Chrysoula BELESSI, Frederic DAVI, Šárka POSPÍŠILOVÁ, Anastasia ATHANASIADOU, Kostas STAMATOPOULOS and David OSCIER. Chromosomal translocations and karyotype complexity in chronic lymphocytic leukemia: A systematic reappraisal of classic cytogenetic data. American Journal of Hematology. Hoboken: Wiley-Blackwell, vol. 89, No 3, p. 249-255. ISSN 0361-8609. doi:10.1002/ajh.23618. 2014.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Chromosomal translocations and karyotype complexity in chronic lymphocytic leukemia: A systematic reappraisal of classic cytogenetic data
Authors BALIAKAS, Panagiotis (300 Greece), Michail ISKAS (300 Greece), Anne GARDINER (826 United Kingdom of Great Britain and Northern Ireland), Zadie DAVIS (826 United Kingdom of Great Britain and Northern Ireland), Karla PLEVOVÁ (203 Czech Republic, belonging to the institution), Nguyen-Khac FLORENCE (250 France), Jitka MALČÍKOVÁ (203 Czech Republic, belonging to the institution), Achlles ANAGNOSTOPOULOS (300 Greece), Sharron GLIDE (826 United Kingdom of Great Britain and Northern Ireland), Sarah MOULD (826 United Kingdom of Great Britain and Northern Ireland), Kristina ŠTĚPANOVSKÁ (203 Czech Republic, belonging to the institution), Martin BREJCHA (203 Czech Republic), Chrysoula BELESSI (300 Greece), Frederic DAVI (250 France), Šárka POSPÍŠILOVÁ (203 Czech Republic, guarantor, belonging to the institution), Anastasia ATHANASIADOU (300 Greece), Kostas STAMATOPOULOS (300 Greece) and David OSCIER (826 United Kingdom of Great Britain and Northern Ireland).
Edition American Journal of Hematology, Hoboken, Wiley-Blackwell, 2014, 0361-8609.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30200 3.2 Clinical medicine
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 3.798
RIV identification code RIV/00216224:14740/14:00078303
Organization unit Central European Institute of Technology
Doi http://dx.doi.org/10.1002/ajh.23618
UT WoS 000331941600003
Keywords in English INDUCED CYTIDINE DEAMINASE; SEQUENCING REVEALS; TP53 MUTATION; PROGNOSTIC SUBGROUPS; GENOMIC ABERRATIONS; NOTCH1 MUTATIONS; POOR-PROGNOSIS; NORMAL FISH; B-CELLS; CLL
Tags kontrola MP, rivok
Tags International impact, Reviewed
Changed by Changed by: Martina Prášilová, učo 342282. Changed: 11/3/2015 15:24.
Abstract
The significance of chromosomal translocations (CTRAs) and karyotype complexity (KC) in chronic lymphocytic leukemia (CLL) remains uncertain. To gain insight into these issues, we evaluated a series of 1001 CLL cases with reliable classic cytogenetic data obtained within 6 months from diagnosis before any treatment. Overall, 320 cases were found to carry 1 CTRAs. The most frequent chromosome breakpoints were 13q, followed by 14q, 18q, 17q, and 17p; notably, CTRAs involving chromosome 13q showed a wide spectrum of translocation partners. KC (3 aberrations) was detected in 157 cases and significantly (P<0.005) associated with unmutated IGHV genes and aberrations of chromosome 17p. Furthermore, it was identified as an independent prognostic factor for shorter time-to-first-treatment. CTRAs were assigned to two categories (i) CTRAs present in the context of KC, often with involvement of chromosome 17p aberrations, occurring mostly in CLL with unmutated IGHV genes; in such cases, we found that KC rather than the presence of CTRAs per se negatively impacts on survival; (ii) CTRAs in cases without KC, having limited if any impact on survival. On this evidence, we propose that all CTRAs in CLL are not equivalent but rather develop by different processes and are associated with distinct clonal behavior. Am. J. Hematol. 89:249-255, 2014. (c) 2013 Wiley Periodicals, Inc.
Links
ED1.1.00/02.0068, research and development projectName: CEITEC - central european institute of technology
EE2.3.20.0045, research and development projectName: Podpora profesního růstu a mezinárodní integrace výzkumných týmů v oblasti molekulární medicíny
MSM0021622430, plan (intention)Name: Funkční a molekulární charakteristiky nádorových a normálních kmenových buněk - identifikace cílů pro nová terapeutika a terapeutické strategie
Investor: Ministry of Education, Youth and Sports of the CR, Functional and molecular characteristics of cancer and normal stem cells - identification of targets for novel therapeutics and therapeutic strategies
NT13493, research and development projectName: Molekulární charakterizace B buněčných receptorů a jejich vztah k evoluci genetických změn u chronické lymfocytární leukémie
PrintDisplayed: 19/4/2024 22:06